Tag Archives: Pfizer

Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs

The J.P. Morgan Healthcare Conference may be over, but that doesn’t mean the dealmaking is. Often, deals that took shape at the meeting materialize later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin, whose fish-oil-derived lipid drug… Read More »

Pfizer loses blockbuster drug patent fight in UK Supreme Court

LONDON (Reuters) – Pfizer (PFE.N) lost the final round in a long-running patent battle in Britain on Wednesday after the country’s highest court ruled against it in a case involving its $ 5 billion-a-year pain drug Lyrica. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.… Read More »